A leading authority on immunology and organ transplantation
Dr. Stiller’s magic touch as a builder pervades every phase of his career. A physician, scientist, administrator, policy innovator and entrepreneur, Dr. Stiller developed one of the most dynamic organ transplant programs in the nation and championed countless other initiatives that have enriched research enterprise in Canada. It was Dr. Stiller who, in the late 1970’s, obtained the promising new drug cyclosporine and organized its first multi-centre clinical trial in kidney transplantation in North America, creating the foundation for subsequent studies that put Canada on the world stage. He was responsible for the ground-breaking research that showed that cyclosporine, an immunosuppressant, could halt the progression of Type 1 Diabetes – demonstrating that it was an immune disorder.
